Kenneth J. Dow

Ken Dow is Vice President, Law at Century Therapeutics. He was previously Vice President, Pharmaceutical Patent Strategy in the Johnson & Johnson Law Department where he was responsible for pre-litigation planning and strategy concerning the patent portfolio for the pharmaceutical sector. Before that he was Vice President, Patent Law at Janssen Biotech, Inc., a subsidiary of Johnson & Johnson. At Janssen Biotech, Mr. Dow was a member of the research management board and was responsible for overseeing all patent matters for the oncology and immunology therapeutic areas, including patent opinions, litigation, preparation and prosecution, as well as licensing and transactional matters. Mr. Dow received his B.S. in Pharmacy from the State University of New York at Buffalo and his J.D. from St. John's University. Mr. Dow was recently the chair of the Biotechnology Innovation Organization IP Counsels Committee.